Clinical trials
Liver Transplant Disorder clinical trials
Below are recruiting liver transplant disorder clinical trials, each written for real people, not researchers. We’re tracking 59 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04672863Recruiting
Mediterranean diet after a first liver transplant
This study tests whether eating a Mediterranean-style diet after a first liver transplant is safe and helpful for recovery or health. It targets adults who are able to follow a nutrition plan and do not have certain complications or conditions that could interfere with diet changes.
Rochester, MinnesotaAges 18 years+ - NCT06808945Recruiting
Prehabilitation program for liver transplant patients
This study tests a pre-surgery exercise and nutrition program (prehabilitation) for people waiting for a liver transplant. It aims to see if getting stronger before surgery can help you recover better after the transplant.
RotterdamAges 18 years+ - NCT06672705RecruitingPhase 1
Epcoritamab for post-transplant lymphoma that didn't respond to treatment
This trial tests a new drug called epcoritamab for people whose PTLD (a type of lymphoma that can happen after an organ transplant) has come back or hasn't been helped by standard treatments. The goal is to see if epcoritamab can shrink or control the cancer.
St Louis, MissouriAges 18 years+ - NCT05786040RecruitingPhase 2
Tafasitamab plus rituximab for PTLD after solid organ transplant
This trial studies tafasitamab plus rituximab to treat a type of lymphoma called post-transplant lymphoproliferative disorder (PTLD) in adults after a solid organ transplant. It’s aimed at helping stop the PTLD when it can be measured and before you’ve had PTLD treatment beyond limited measures like steroid or reducing anti-rejection drugs.
New Brunswick, New JerseyAges 18 years+ - NCT05761483Recruiting
Endoscopic treatment for bile duct narrowing after liver transplant
This trial tests an endoscopic (camera-based) approach to treat bile duct narrowing that happens after a liver transplant. It may help improve bile flow and liver blood test results when the narrowing is in the bile duct area near where the liver’s bile ducts split.
Roma, RMAges 18 years+ - NCT05953948Enrolling by invitation
Smartphone case management program for liver transplant patients
This trial studies whether an “intelligent” phone-based case management program can help people after a liver transplant. You may be able to participate if you’re a liver transplant recipient and can use a smartphone, but not if you have liver-related confusion.
Taoyuan, TYAges 20 years+ - NCT07329296Enrolling by invitation
Liver regeneration after living donor transplant study
This study looks at how the donor's liver grows back after donating a part of it for a living donor liver transplant. If you have donated a part of your liver between 2004 and 2026, joining could help doctors learn more about liver healing.
Rotterdam, South HollandAges 18–60 - NCT05186116Recruiting
Liver transplant for colon cancer that cannot be removed
This trial studies whether liver transplant (rather than removing the liver tumors) can help some people with colon or rectal cancer spread to the liver. It’s meant for people whose cancer has responded or stayed controlled on standard treatments and who have no cancer outside the liver.
Modena, MOAges 18–77 - NCT05308628Recruiting
Tests for liver scar (fibrosis) in children after liver transplant
This study checks how well a liver “fibrosis panel” test can evaluate scarring in children who have had their first liver transplant. Your child may be helped by getting extra monitoring of liver scarring, and the study may improve how doctors assess recovery and risk over time.
ShanghaiAges 2 months–18 years - NCT05475613RecruitingPhase 2
Immunotherapy to shrink advanced liver cancer before transplant
This trial tests an immunotherapy “downstaging” plan to shrink hepatocellular carcinoma (a type of liver cancer) so it may become treatable with a liver transplant. You may be eligible if your cancer is beyond transplant limits but is still only in the liver, and you meet specific liver function and health requirements.
Guangzhou, GuangdongAges 18–75 - NCT06169592Recruiting
Bleeding and Clotting Risks After Living Donor Liver Transplant
This study is for people with severe liver cirrhosis who are getting a liver transplant from a living donor. It looks at the risk of bleeding or clotting problems after the transplant, to help doctors better manage these risks.
TashkentAges 18–70 - NCT06455280RecruitingPhase 1
A study of Siplizumab for autoimmune liver disease patients awaiting transplant
This trial tests a drug called Siplizumab in people with autoimmune hepatitis or primary sclerosing cholangitis who are on the liver transplant waitlist. It aims to see if the drug can help manage their condition before and after transplant.
New York, New YorkAges 18 years+ - NCT06749405Recruiting
Using Quantra to Guide Transfusions During Liver Transplant
This study tests a special tool called Quantra, which helps doctors decide when to give blood products during your liver transplant. The goal is to make sure you get just the right amount of transfusions, which could improve your safety and recovery.
ToulouseAges 18 years+ - NCT06950788Recruiting
Glucose changes in cirrhosis patients around liver transplant
This study looks at how the body processes sugar (glucose) in people with cirrhosis who are waiting for a liver transplant. It aims to track changes in blood sugar control before and after transplant, which may help improve care for patients with liver disease.
Chicago, IllinoisAges 18–75 - NCT07269041RecruitingPhase 1/Phase 2
Immune tolerance after liver transplant
This trial tests a way to help your body accept your liver transplant without needing lifelong anti-rejection drugs. It uses your living donor's stem cells to train your immune system to not attack the new liver.
Los Angeles, CaliforniaAges 18 years+ - NCT07305012Recruiting
Healthy lifestyle tool for older liver and kidney transplant recipients
This study tests a new tool designed to help people aged 60 or older who have received a liver or kidney transplant improve their eating and physical activity habits. It aims to see if the tool is easy to use and helpful for maintaining a healthy lifestyle.
Bologna, BOAges 60 years+ - NCT07561138Recruiting
Nutrition and Exercise Training Before Liver Transplant
This study tests whether eating better and doing gentle exercise before your liver transplant can help you stay healthier and recover better after surgery. You'll work with a nutrition expert and exercise specialist to prepare your body for transplant.
Athens, AtticaAges 18–70 - NCT05082077Enrolling by invitation
Liver transplant donor data registry for better organ preservation
This study builds a global registry that tracks how donor livers are matched and preserved for transplant. It may help improve how doctors keep donor livers viable before surgery by learning from real-world cases.
Birmingham, AlabamaAges 18 years+ - NCT04234139Enrolling by invitation
Study of severe alcoholic hepatitis patients before early liver transplant
This study follows people with severe alcoholic hepatitis who are being considered for an early liver transplant before they’ve been sober for 6 months. It aims to better understand this group’s situation and ethics/safety as early transplantation plans are made.
Baltimore, MarylandAges 18 years+ - NCT06832189RecruitingPhase 1
Testing everolimus and epoetin for liver transplant tolerance
This trial is testing whether a combination of two drugs, everolimus and epoetin, can help liver transplant recipients gradually reduce their anti-rejection medicines. If successful, it may lead to long-term transplant tolerance with fewer side effects.
San Francisco, CaliforniaAges 18 years+ - NCT06400771RecruitingPhase 1
Safety of DNP007 in Healthy Volunteers
This study tests the safety of a new drug called DNP007 in healthy volunteers. It is a Phase 1 trial, meaning it's one of the first steps in humans to see if the drug is safe and how the body handles it.
SeoulAges 19–55 - NCT06060392Recruiting
Semaglutide pill for liver fat in transplant patients with diabetes
This study tests if an oral semaglutide pill can reduce liver fat and improve body composition in people who have had a liver transplant and have diabetes. It may help manage weight and blood sugar after transplant.
Gurgaon, HaryanaAges 30 years+ - NCT07315204Recruiting
Liver viability test during machine perfusion
This trial tests a new way to check if a donated liver is healthy while it is kept on a machine that keeps it alive before transplant. Doctors measure a substance called FMN in the fluid that flows through the liver and in bile. This could help them know how well the liver might work after transplant.
Cleveland, OhioAges 18 years+ - NCT06302205Recruiting
Home exercise program after liver transplant
This study tests whether a home-based exercise program can help people who recently had a liver transplant. It compares different exercise intensities to see which works best for recovery.
Leuven, Vlaams-BrabantAges 18 years+
Hear when a new Liver Transplant Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for liver transplant disorder?
- Yes. Clin2 currently lists 59 recruiting liver transplant disorder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a liver transplant disorder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a liver transplant disorder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.